Despite a drop in COVID product demand, Pfizer Inc (PFE) surpasses EPS expectations and advances key strategic initiatives.

Taking a closer look at the numbers, Comirnaty sales slipped 19% globally to $1.15 billion, the Prevnar franchise experienced a 3% global sales decline to $1.7 billion, and Abrysvo’s performance decreased 22% to sales of $279 million in Q3.

Due to the litigation Pfizer filed Friday and Monday against Metsera, Novo Nordisk and the biotech’s lead shareholder, CEO Albert Bourla was limited in what he could say. But he said Pfizer was the best fit for Metsera.

Pfizer has increased its annual profit forecast and reported higher-than-expected profits for the third quarter amid a legal battle with Novo Nordisk over obesity drug developer Metsera. Despite declining COVID-19-related sales,

CHICAGO -- Pfizer has begun a Phase 2 and 3 clinical trial of its COVID-19 antiviral treatment, Paxlovid, in children ages 6 to 17, the company said Wednesday in a news release. The study will evaluate the safety and efficacy of the treatment in children ...

Experts are still encouraging people to take the drug if prescribed. When Laura Martin tested positive for COVID-19 last month during an extended stay in California, she was prescribed Paxlovid, the highly touted antiviral drug created by Pfizer.